Penumbra Inc

PEN · Moat type: UNBESTIMMT

MoatScore

7/10

Fair Value

155 USD

Margin of Safety

-105.1 %

Rating

BEOBACHTEN

Penumbra Inc. develops and markets medical devices for interventional treatment of vascular diseases and thromboses, particularly systems for mechanical thrombectomy as well as embolization products for neurology and vascular surgery, and generates revenues primarily through direct device and consumables sales to hospitals.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.